Published in Helicobacter on January 01, 2002
Sequential and concomitant therapy with four drugs is equally effective for eradication of H pylori infection. Clin Gastroenterol Hepatol (2009) 2.15
Cholesterol enhances Helicobacter pylori resistance to antibiotics and LL-37. Antimicrob Agents Chemother (2011) 1.02
Helicobacter pylori and pregnancy-related disorders. World J Gastroenterol (2014) 0.90
Dual proton pump inhibitor plus amoxicillin as an empiric anti-H. pylori therapy: studies from the United States. J Gastroenterol (2010) 0.87
Clinical practice: diagnosis and evaluation of dyspepsia. J Clin Gastroenterol (2010) 0.86
Short-term celecoxib intervention is a safe and effective chemopreventive for gastric carcinogenesis based on a Mongolian gerbil model. World J Gastroenterol (2009) 0.82
Orally administered CpG oligodeoxynucleotide induces production of CXC and CC chemokines in the gastric mucosa and suppresses bacterial colonization in a mouse model of Helicobacter pylori infection. Infect Immun (2003) 0.81
Posttreatment 13C-urea breath test is predictive of antimicrobial resistance to H. pylori after failed therapy. J Gen Intern Med (2005) 0.81
Optimal length of triple therapy for H pylori eradication in a population with high prevalence of infection in Chile. World J Gastroenterol (2007) 0.80
In vitro activity of fosfomycin alone and in combination with amoxicillin, clarithromycin and metronidazole against Helicobacter pylori compared with combined clarithromycin and metronidazole. Eur J Clin Microbiol Infect Dis (2005) 0.78
Antibiotics resistance of Helicobacter pylori and treatment modalities in children with H. pylori infection. Korean J Pediatr (2014) 0.77
Management of Helicobacter pylori infection--the Maastricht IV/ Florence Consensus Report. Gut (2012) 12.62
Gastric phytobezoars may be treated by nasogastric Coca-Cola lavage. Eur J Gastroenterol Hepatol (2002) 2.07
Dyspeptic symptoms and endoscopic findings in the community: the Loiano-Monghidoro study. Am J Gastroenterol (2009) 1.58
Frequent loss of hMLH1 by promoter hypermethylation leads to microsatellite instability in adenomatous polyps of patients with a single first-degree member affected by colon cancer. Cancer Res (2003) 1.20
Gastric bezoar treated endoscopically with a carbonated beverage: case report. Gastrointest Endosc (2004) 1.13
Gastric cancer: epidemiologic aspects. Helicobacter (2013) 1.09
Gastric cancer: clinical aspects, epidemiology and molecular background. Helicobacter (2011) 1.07
Intrafamilial spread of Helicobacter pylori: a genetic analysis. Helicobacter (2003) 1.03
Effect of three bowel preparations on video-capsule endoscopy gastric and small-bowel transit time and completeness of the examination. Scand J Gastroenterol (2007) 1.02
13C-urea breath test to assess Helicobacter pylori bacterial load. Helicobacter (2005) 0.95
Helicobacter pylori: gastric cancer and extragastric intestinal malignancies. Helicobacter (2012) 0.88
Clinical aspects of gastric cancer and Helicobacter pylori--screening, prevention, and treatment. Helicobacter (2010) 0.87
Ethical and legal implications in seeking and providing a second medical opinion. Dig Dis (2007) 0.84
Helicobacter pylori and clinical aspects of gastric cancer. Helicobacter (2009) 0.82
Triple levofloxacin-based rescue therapy is an accepted empirical third-line treatment. Am J Gastroenterol (2006) 0.78
Mucin Expression in the Esophageal Malignant and Premalignant States: A Systematic Review and Meta-analysis. J Clin Gastroenterol (2017) 0.75